Compare Globus Medical Inc. Class A Common Stock (GMED) vs Lamb Weston Holdings Inc (LW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Lamb Weston Holdings Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Lamb Weston Holdings Inc trades at $53.63 (market cap $7.31B). The key difference: Globus Medical Inc. Class A Common Stock is the larger of the two by market cap, and Lamb Weston Holdings Inc pays a 2.87% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Lamb Weston Holdings Inc for 66 Days on average.
| GMED | LW | |
|---|---|---|
Market Cap | $10.25B | $7.31B |
Volume | 1,059,528 | 3,751,735 |
Sector | Health | Consumer Staples |
52-Week High | $96.82 | $66.57 |
52-Week Low | $58.33 | $38.48 |
Typical Hold Time | 0 Days | 66 Days |
Enterprise Value | $9.76B | $11.10B |
Dividend Yield | — | 2.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Lamb Weston (LW) trades at $51.96, up 3.55% today, showing strong momentum with four consecutive quarterly earnings beats. The stock exhibits bullish technical signals with moving averages supporting upward trends, though RSI levels suggest potential overbought conditions. Fundamentally, the company maintains solid profitability with 14.17% ROE and 3.85% net margin, while trading at reasonable valuations of 28.39 P/E and 1.09 P/S ratios. Recent dividend payments of $0.38 demonstrate shareholder returns.
LW presents a balanced investment case with analyst consensus at $53.71 offering modest upside. The company's consistent earnings outperformance and cost-saving initiatives provide support, but declining profit margins from 18.85% in 2023 to 3.84% projected for 2026 represent significant headwinds. High debt levels at $3.68 billion and ongoing legal investigations create additional risk factors that warrant careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Lamb Weston Holdings Inc
Lamb Weston is the world's second-largest producer of branded and private-label frozen potato products, such as French fries, sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. The company also has a small appetizer business that produces onion rings, mozzarella sticks, and cheese curds. Including joint ventures, 63% of fiscal 2022 revenue was U.S.-based, with the remainder stemming from Europe, Canada, Japan, China, Korea, Mexico, and several other countries. Lamb Weston's customer mix is estimated 58% quick-serve restaurants, 19% full-service restaurants, 8% other food services (hotels, commercial cafeterias, arenas, schools), and 16% retail. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Read more on LW →
